Search

Anthony H Nguyen

Examiner (ID: 17425)

Most Active Art Unit
2854
Art Unit(s)
3307, 2854, 2853
Total Applications
2014
Issued Applications
1600
Pending Applications
48
Abandoned Applications
337

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6769930 [patent_doc_number] => 20030215870 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-20 [patent_title] => 'Isolated and purified 12R-lipoxygenase polypeptide and polynucleic acid encoding the same' [patent_app_type] => new [patent_app_number] => 10/445484 [patent_app_country] => US [patent_app_date] => 2003-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 21791 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20030215870.pdf [firstpage_image] =>[orig_patent_app_number] => 10445484 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/445484
Isolated and purified 12R-lipoxygenase polypeptide and polynucleic acid encoding the same May 26, 2003 Abandoned
Array ( [id] => 7448996 [patent_doc_number] => 20040009946 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-15 [patent_title] => 'Modulation of PTP1B expression and signal transduction by RNA interference' [patent_app_type] => new [patent_app_number] => 10/444925 [patent_app_country] => US [patent_app_date] => 2003-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 27367 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20040009946.pdf [firstpage_image] =>[orig_patent_app_number] => 10444925 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/444925
Modulation of PTP1B expression and signal transduction by RNA interference May 22, 2003 Abandoned
Array ( [id] => 7363486 [patent_doc_number] => 20040014957 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-22 [patent_title] => 'Oligonucleotides having modified nucleoside units' [patent_app_type] => new [patent_app_number] => 10/444628 [patent_app_country] => US [patent_app_date] => 2003-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 71178 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20040014957.pdf [firstpage_image] =>[orig_patent_app_number] => 10444628 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/444628
Oligonucleotides having modified nucleoside units May 22, 2003 Abandoned
60/651504 Oligonucleotide compositions and methods for the modulation of the expression of B7 protein May 22, 2003 Pending
Array ( [id] => 7358496 [patent_doc_number] => 20040014108 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-22 [patent_title] => 'Oligonucleotides having modified nucleoside units' [patent_app_type] => new [patent_app_number] => 10/444298 [patent_app_country] => US [patent_app_date] => 2003-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50598 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20040014108.pdf [firstpage_image] =>[orig_patent_app_number] => 10444298 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/444298
Oligonucleotides having modified nucleoside units May 22, 2003 Abandoned
Array ( [id] => 6725541 [patent_doc_number] => 20030207853 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-06 [patent_title] => 'Cholesterol and hedgehog signaling' [patent_app_type] => new [patent_app_number] => 10/442435 [patent_app_country] => US [patent_app_date] => 2003-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11510 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20030207853.pdf [firstpage_image] =>[orig_patent_app_number] => 10442435 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/442435
Cholesterol and hedgehog signaling May 19, 2003 Issued
Array ( [id] => 7445666 [patent_doc_number] => 20040009602 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-15 [patent_title] => 'DNA modifying molecules and methods of use thereof' [patent_app_type] => new [patent_app_number] => 10/438076 [patent_app_country] => US [patent_app_date] => 2003-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 26986 [patent_no_of_claims] => 76 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20040009602.pdf [firstpage_image] =>[orig_patent_app_number] => 10438076 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/438076
DNA modifying molecules and methods of use thereof May 12, 2003 Abandoned
Array ( [id] => 7251879 [patent_doc_number] => 20050074760 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-07 [patent_title] => 'Enzymatic nucleic acids containing 5\'-and/or 3\'-cap structures' [patent_app_type] => utility [patent_app_number] => 10/430562 [patent_app_country] => US [patent_app_date] => 2003-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 19968 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20050074760.pdf [firstpage_image] =>[orig_patent_app_number] => 10430562 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/430562
Enzymatic nucleic acids containing 5'-and/or 3'-cap structures May 5, 2003 Abandoned
Array ( [id] => 7310614 [patent_doc_number] => 20040142946 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-22 [patent_title] => 'Modified nucleosides and nucleotides and use thereof' [patent_app_type] => new [patent_app_number] => 10/399951 [patent_app_country] => US [patent_app_date] => 2003-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7910 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20040142946.pdf [firstpage_image] =>[orig_patent_app_number] => 10399951 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/399951
Modified nucleosides and nucleotides and use thereof Apr 22, 2003 Abandoned
Array ( [id] => 5738470 [patent_doc_number] => 20060008861 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-12 [patent_title] => 'Incorporation of anaerobic bacteria in feed formulation' [patent_app_type] => utility [patent_app_number] => 10/511202 [patent_app_country] => US [patent_app_date] => 2003-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1795 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20060008861.pdf [firstpage_image] =>[orig_patent_app_number] => 10511202 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/511202
Incorporation of anaerobic bacteria in feed formulation Apr 13, 2003 Abandoned
Array ( [id] => 6821710 [patent_doc_number] => 20030219871 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-27 [patent_title] => 'Host cells having improved cell survival properties and methods to generate such cells' [patent_app_type] => new [patent_app_number] => 10/402017 [patent_app_country] => US [patent_app_date] => 2003-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 23616 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20030219871.pdf [firstpage_image] =>[orig_patent_app_number] => 10402017 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/402017
Host cells having improved cell survival properties and methods to generate such cells Mar 27, 2003 Abandoned
Array ( [id] => 7224446 [patent_doc_number] => 20040072743 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'Pharmaceutical composition of modified pna molecules' [patent_app_type] => new [patent_app_number] => 10/240641 [patent_app_country] => US [patent_app_date] => 2003-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8790 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20040072743.pdf [firstpage_image] =>[orig_patent_app_number] => 10240641 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/240641
Pharmaceutical composition of modified pna molecules Mar 20, 2003 Abandoned
Array ( [id] => 7348640 [patent_doc_number] => 20040248296 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'HIV therapeutic' [patent_app_type] => new [patent_app_number] => 10/393411 [patent_app_country] => US [patent_app_date] => 2003-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 19474 [patent_no_of_claims] => 100 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20040248296.pdf [firstpage_image] =>[orig_patent_app_number] => 10393411 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/393411
HIV therapeutic Mar 19, 2003 Abandoned
Array ( [id] => 6796909 [patent_doc_number] => 20030175783 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'Methods and means for monitoring and modulating gene silencing' [patent_app_type] => new [patent_app_number] => 10/385546 [patent_app_country] => US [patent_app_date] => 2003-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11244 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 187 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20030175783.pdf [firstpage_image] =>[orig_patent_app_number] => 10385546 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/385546
Methods and means for monitoring and modulating gene silencing Mar 11, 2003 Abandoned
Array ( [id] => 7470226 [patent_doc_number] => 20040121348 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-24 [patent_title] => 'Compositions and methods for treating pancreatic cancer' [patent_app_type] => new [patent_app_number] => 10/384434 [patent_app_country] => US [patent_app_date] => 2003-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10200 [patent_no_of_claims] => 80 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20040121348.pdf [firstpage_image] =>[orig_patent_app_number] => 10384434 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/384434
Compositions and methods for treating pancreatic cancer Mar 6, 2003 Abandoned
Array ( [id] => 81803 [patent_doc_number] => 07745417 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-29 [patent_title] => 'Nucleosides or nucleotides having novel unnatural bases and use thereof' [patent_app_type] => utility [patent_app_number] => 10/521454 [patent_app_country] => US [patent_app_date] => 2003-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 19 [patent_no_of_words] => 16396 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/745/07745417.pdf [firstpage_image] =>[orig_patent_app_number] => 10521454 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/521454
Nucleosides or nucleotides having novel unnatural bases and use thereof Feb 27, 2003 Issued
Array ( [id] => 6740775 [patent_doc_number] => 20030158144 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => 'Antisense modulation of estrogen receptor beta expression' [patent_app_type] => new [patent_app_number] => 10/376566 [patent_app_country] => US [patent_app_date] => 2003-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27686 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20030158144.pdf [firstpage_image] =>[orig_patent_app_number] => 10376566 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/376566
Antisense modulation of estrogen receptor beta expression Feb 26, 2003 Abandoned
Array ( [id] => 7436186 [patent_doc_number] => 20040002465 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-01 [patent_title] => 'Polyene macrolide derivatives, use for vectoring molecules' [patent_app_type] => new [patent_app_number] => 10/373195 [patent_app_country] => US [patent_app_date] => 2003-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 10920 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20040002465.pdf [firstpage_image] =>[orig_patent_app_number] => 10373195 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/373195
Polyene macrolide derivatives, use for vectoring molecules Feb 25, 2003 Abandoned
Array ( [id] => 7136759 [patent_doc_number] => 20050181485 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-18 [patent_title] => 'Cellulose digesting enzyme gene and utilization of the gene' [patent_app_type] => utility [patent_app_number] => 10/505474 [patent_app_country] => US [patent_app_date] => 2003-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 25383 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20050181485.pdf [firstpage_image] =>[orig_patent_app_number] => 10505474 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/505474
Cellulose digesting enzyme gene and utilization of the gene Feb 24, 2003 Abandoned
Array ( [id] => 7020040 [patent_doc_number] => 20050222059 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'Egfrviii specific monoclonal antibody and egfrviii ribozymes and use to detect, treat or prevent egfrviii associated cancer' [patent_app_type] => utility [patent_app_number] => 10/505591 [patent_app_country] => US [patent_app_date] => 2003-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 13445 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20050222059.pdf [firstpage_image] =>[orig_patent_app_number] => 10505591 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/505591
Egfrviii specific monoclonal antibody and egfrviii ribozymes and use to detect, treat or prevent egfrviii associated cancer Feb 24, 2003 Abandoned
Menu